Topic

Exploring Advances in Single-Use Bioprocessing Technologies for Efficient Biologics Manufacturing; Case study, insights & perspectives

Date & Time

25th September 2025 | 11:00 AM SGT

Synopsis

The rapid evolution of biologics manufacturing is driving the need for highly adaptable, contamination-controlled, and economically viable production platforms. Single-use bioprocessing technologies (SUS) have emerged from niche applications to mainstream adoption, enabling streamlined facility design, enhanced production agility, and sustainable operations.

This webinar provides a deep technical dive into the latest advancements in SUS, covering next-generation polymer chemistries, closed-system process designs, automation-enabled monitoring, and hybrid facility architectures that combine stainless steel and disposable components.

Through real-world case studies and data-driven insights, participants will explore operational, economic, and regulatory aspects of SUS integration in monoclonal antibody production, and gain strategies for future-ready, flexible biologics manufacturing.

Speaker

Dr. Ramesh Mundlamuri

Dr. Ramesh Mundlamuri

Technical Director, Duoning Biotech

The Presenters Will Discuss

Technological innovations in SUS, including advanced materials, extractables/leachables control, and automation-enabled monitoring.
Integration of SUS in upstream and downstream workflows, demonstrating operational efficiencies, cost reductions, and accelerated multi-product changeovers.
Hybrid facility designs that blend stainless steel and disposable systems to optimize flexibility, scalability, and economics.
Regulatory and quality perspectives for SUS implementation, including global compliance, extractables/leachables qualification, and lifecycle risk management.
Future trends in single-use bioprocessing, including AI-driven optimization, digital twins, continuous manufacturing, and sustainability initiatives.

Key Learning Objectives

Understand the role of single-use technologies in flexible, modular, and sustainable biologics manufacturing.
Evaluate operational and economic benefits of SUS through real-world case studies, including CAPEX/OPEX savings and reduced cleaning validation.
Examine regulatory requirements, quality assurance practices, and lifecycle risk considerations in SUS deployment.
Explore hybrid facility architectures and integration strategies for upstream and downstream processes.
Identify emerging technologies and trends shaping the future of single-use bioprocessing, including digitalization, AI, and circular economy approaches.

Speaker Bio

Dr Ramesh Mundlamuri has over 19 years of experience in various biopharmaceutical organizations and has ample experience in various divisions and sections of the biopharmaceutical industry, including Research & Development, Technology Transfer, Commercial Manufacturing, Product & Process Development, Operations Management and so on.

Prior to joining Duoning, he worked at Biological E in Hyderabad, India. In his role as Assistant General Manager, he led the commercial manufacturing of polysaccharide conjugate and protein-based Vaccines. Before that, he worked for Panacea Biotech, Sartorius, Sanofi and Krebs Biochemical Industries.

Dr Ramesh Mundlamuri is well-versed in cGMP, GLP, GDP and various regulatory bodies (WHO, EU, ROW, FDA, NRA). He also possesses extensive experience in the management of several vaccines, including polysaccharide vaccines, recombinant viral proteins, conventional vaccines and carrier protein.

Register Now

By clicking any of these options, you are agreeing to receive marketing emails, newsletters and other promotional communications from Duoning Bio from time to time. You have a right to withdraw your consent at any time, by clicking here. We may still continue to send you service-related and other non-promotional communications.

Would you like one of our specialists to reach out to you?

**Under no circumstances we will share or sell your email and contact information with any govt or private entity.